Skip to main content

Paul Billings

Biological Dynamics has appointed Paul Billings to its board of directors. Billings' addition increases board membership to four directors.

Billings currently serves as an executive-in-residence at Janssen Diagnostics, a division of Johnson & Johnson, and is the medical director of the IMPACT Cancer Care Program at Thermo Fisher Scientific. Previously, he has served on the scientific advisory board of the US Food and Drug Administration and the Genomic Medicine advisory committee at the Department of Veterans Affairs. Billings has also held academic appointments at Harvard University, the University of California San Francisco, Stanford University, and UC Berkeley; has served as a physician at a number of leading medical centers; and served as chief medical officer of Life Technologies and the genetic sciences division of Thermo Fisher Scientific.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.